Abstract.
Background Active smoking and passive exposure to environmental tobacco smoke is association with increased risk of invasive pneumococcal disease, including pneumonia. The mechanism for this association is unclear. Adhesion of S. pneumoniae is mediated by the receptor for platelet activating factor (PAFR) expressed on lower airway cells. In this study, we sought to assess PAFR expression in smokers' airways, and model the effect of cigarette smoke extract (CSE) on pneumococcal adhesion to A549 cells in vitro.
Methods
Expression of PAFR was assessed by immunostaining and image analysis of bronchial biopsies from healthy active-smokers and never-smokers.
Pneumococcal adhesion in vitro was assessed using in A549 cells exposed to cigarette smoke extract (CSE <1%) and expressed as colony forming units (CFU)/mL. The functional role of PAFR was determined using the specific receptor blocker CV-3988, and PAFR transcript level by quantitative RT-PCR.
Results
No PAFR expression was found in 11/11 never-smokers. PAFR expression was found in 6/16 active smokers (Chi square P<0.001). CSE >0.5% increased pneumococcal adhesion to A549 cells (P<0.01 vs. control). CSE 0.5% increased PAFR transcript level (P<0.05) and stimulated-adhesion was abrogated by coincubation with the PAFR receptor blocker.
Conclusion.
Cigarette smoke upregulates pneumococcal adhesion to lower airway cells via a PAFR-dependent mechanism. Since we have previously reported that fossil-fuel pollution upregulates pneumococcal adhesion via PAFR, these findings suggest that there are common mechanisms underlying vulnerability to pneumonia associated with emissions from combustion fuels/products.
BACKGROUND
Epidemiological studies suggest that exposure to cigarette smoke is a major risk factor for infection by Streptococcus pneumoniae (pneumococcus). Nuorti et al 1 reported that for active smokers, the adjusted risk for invasive pneumococcal disease is 4.1 (95% confidence interval; 2.4 to 7.3) , and 2.5 (1.2 to 5.1) for adults exposed to environmental tobacco smoke (ETS). Suzuki et al 2 reported that ETS was associated with paediatric hospital admissions with pneumonia (adjusted OR 1.55, 1.25 to 1.92), and estimated that 28% of pneumonia in Vietnamese children is attributable to ETS exposure . Since S. pneumoniae is the major cause of pneumonia 3 , these data suggest that vulnerability to pneumococcal pneumonia is increased by both active and passive exposure to cigarette smoke.
Biological plausibility for this association is provided by animal models. For example, chronic exposure of mice to cigarette smoke followed by pneumococcal infection, increases morbidity and colony forming unit counts (CFU) of pneumococci in lung tissue 4 .
To date, the mechanism whereby cigarette smoke increases vulnerability to pneumococcal pneumonia is unclear. A prerequisite step for the development of pneumonia is the ability of bacteria to adhere to lower airway cells 3 .
Pneumococcal adhesion to lower airway cells is enhanced by heterogeneous stimuli including; acid 5 , respiratory viral infection 6 , and interleukin-1 (IL) 7 .
For clinically relevant strains of S. pneumoniae, adhesion to lower airway cells is achieved by phosphorylcholine in the bacterial cell wall interacting with the receptor for platelet activating factor (PAFR) expressed on the surface of host cells 5 6 7 . Normal internalisation of PAFR subsequently transports pneumococci through the cell wall into the cytoplasm 7 . Recently, we reported that carbonaceous particulate matter (PM) from urban air pollution increases adhesion of S pneumoniae to lower airway cells in vitro 8 . We therefore hypothesised that cigarette smoke upregulates pneumococcal adhesion to lower airway cells via a PAFR-dependent mechanism. In this study, we sought to assess PAFR expression in bronchial epithelial cells from healthy adult smokers, and model the effect of cigarette smoke on pneumococcal adhesion using cultured human airway cells.
METHODS

Subjects
Active smokers without clinical lung function impairment and healthy neversmokers underwent bronchoscopy and bronchial biopsy. All subjects gave written, informed consent approved by the Human Research Ethics Committee (Tasmania) Network (Approval number: H0007017). Potential participants were interviewed and examined by a respiratory physician. Subjects with a history suggestive of asthma, other respiratory disorders and uncontrolled comorbidities were excluded. Non-smokers had no history of respiratory illness or smoking. For normal smokers the inclusion criteria were; a minimum 10 packyear history of cigarette smoking with spirometry within normal limits (FEV1>80% of predicted, and FEV1/FVC>70%). Bronchoscopies were performed as previously described 9 . Endobronchial biopsies were taken from subsegmental carinae of the right lower lobe of each patient, using alligator forceps (FB-15C; Olympus, Tokyo, Japan).
Immunostaining
Bronchial biopsies were fixed in 4% neutral buffered formalin for 2 h and subsequently processed into paraffin through graded alcohol and xylene using a 
Biopsy analysis
Computer-assisted image analysis was performed (Leica DM 2500 microscope, Microsystems, Germany), with a Spot insight 12 digital camera and Image Pro V5.1 (Media Cybernetics, USA) software. Expression of PAFR was measured on randomised and coded slides an operator thus blinded to smoking status and expressed as either; i) percentage of epithelium stained for PAFR, or ii) the proportion of subjects exhibiting any PAFR staining of bronchial epithelium.
Cell culture
A549, a human type II pneumocyte cell line, was obtained from Sigma Aldrich 
Cigarette smoke extract
Cigarette smoke extract in filter material was prepared at the Institute of Clinical Science Lund, (Sweden), as previously described 10 . Briefly, 3 cigarettes (0.8 mg nicotine per cigarette; Marlboro®, Philip Morris USA, Pittsburgh, PA, USA) were "smoked" by a water aspirator, and cigarette smoke aspirated through a cotton wool filter. Extract of cigarette smoke (CSE) was obtained by vortexing the cotton wool filter in 1 ml DMSO (CSE 100%) 10 . We previously determined that the nicotine content of CSE was 0.1 to 0.15 mg/mL 10 . CSE was subsequently diluted in medium and used in the range 0.025% to 1%. DMSO per se at these concentrations did not alter pneumococcal adhesion.
Adhesion
Adhesion of pneumococci to A549 cells was assessed using a standard bacterial adhesion assay 7 11 8 . Briefly, airway cells at 2 x 10 5 /mL were seeded in 24-well plates (Costar, Sigma Aldrich Poole, Dorset, UK). CSE (0.025 to 1%) was added to cell monolayers and incubated for 4 h at 37 O C. CSE was removed by washing twice with Dulbecco's Modified Eagle Medium (Invitrogen Ltd, Paisley, UK) and pneumococci added and incubated for 2 h 5 . Cell monolayers were washed five times and cells removed from the tissue culture plate by trypsin-EDTA, and lysed with ice cold sterile distilled water for 10 min. Serial lysate dilutions were plated for quantitative bacterial culture and assessment of colony forming unit count (CFU/mL) 12 . The role of PAFR in mediating adhesion was assessed by coincubation with a PAFR antagonist. A stock solution of the specific PAFR antagonist CV-3988 13 (Enzo Life Sciences, Plymouth Meeting, PA ) was prepared at 1 mM in ethanol then diluted in medium to a final concentration of 10 M. We established that CSE did not stimulate pneumococcal proliferation per se (data not shown).
Cell viability
Cell viability by lactate dehydrogenase (LDH) release was done according to the 
Statistical analysis
Normally distributed data are summarised as mean (standard error of the mean; SEM) and analysed using GraphPad Prism version 5.03 (GraphPad Software Inc., La Jolla, CA), with analyses done by unpaired t test. For non-normally distributed data, comparisons were done by Mann Whitney and Chi-Square tests, and data summarised as median (range, 25 th , 75 th centile). Cell culture data were validated by at least 3 separate experiments done at different times. For mRNA transcript number, the mean of raw data of control samples (n=5) was assigned 100% and the SEM converted to a percentage of the raw value. A P value of <0.05 was considered significant.
RESULTS
Bronchial biopsies for immunostaining were obtained from 16 healthy activesmokers and 11 never-smokers (Table 1 ). There was no difference in FEV1/FVC ratio between the 2 groups, although FEV1 was lower in active-smokers (P<0.01, Table 1 ). Six (38%) smokers exhibited extensive epithelial PAFR immunostaining ( Fig 1A) . There was no significant difference in age, pack-years, or lung function between PAFR-positive and PAFR-negative active smokers.
PAFR staining of bronchial cells was not present in never-smokers (Chi-Square, never-smokers vs. smokers, P<0.001 , Fig 1B) . The median PAFR immunostaining was therefore higher in smokers compared with never-smokers (0 (0 to 0.464) vs. 0 (0 to 0) units, P<0.05).
Cigarette smoke extract up to 1% was not cytotoxic to A549 cells assessed by the MTT assay (Fig 2) , and did not result in deposition of black particulate matter on cultured cells (Fig 3 A,B) . Exposure of A549 cells to CSE 1%, but not 0.5%, induced a modest increase in LDH release (P<0.01 vs. medium control, Fig 4) .
Cigarette smoke extract at 0.5%, and 1.0%, increased pneumococcal adhesion to A549 cells (P<0.01 vs. control, Fig 5) . Co-incubation with the specific PAFR antagonist CV3988 abrogated the CSE-stimulated increase in pneumococcal adhesion (P<0.001 CSE 0.5%+CV3988 vs. CSE 0.5%, Fig 6) , but had no effect on basal pneumococcal adhesion to A549 cells (data not shown).
DISCUSSION
In this study we found that PAFR, a host receptor co-opted by pneumococci to adhere to, and infect, lower airway cells, was not expressed on bronchial epithelial cells from never-smokers, but was present in a proportion of active smokers. Using an in vitro adhesion assay we also found upregulation of pneumococcal adhesion by CSE in cultured airway epithelial cells. Pneumococcal adhesion stimulated by CSE was blocked by a PAFR antagonist. The time from last cigarette to bronchial biopsy was not recorded, we cannot therefore assess whether PAFR positivity was limited to those subjects who smoked on the day of the biopsy. Whether PAFR expression in smokers is associated with increased pneumococcal adhesion in vivo is also unknown.
However, previous studies suggest that the airway cells of smokers have an increased capacity to support pneumococcal adhesion. Riise et al 16 , using fixed cells from bronchial biopsies, found a non-significant trend for increased adhesion of S. pneumoniae to airway cells of smokers with chronic bronchitis . El Ahmer et al 17 reported increased binding of S. pneumoniae to buccal epithelial cells from active smokers compared with non-smokers. More direct evidence for a role of PAFR in pneumococcal infection is provided by animal models. For example, vulnerability to pneumococcal pneumonia in rabbits exposed to exogenous IL-1 is a direct result of increased PAFR expression 7 . In addition, increased pulmonary PAFR expression in mice after influenza virus infection is associated with increased vulnerability to subsequent pneumococcal pneumonia 18 , and knockout of PAFR in this model reduces disease severity and mortality 18 .
We chose to assess pneumococcal adhesion in vitro using an alveolar cell line since the alveoli are a major site for the development of pneumonia 19 . Cigarette smoke extract is reported to induce significant cytotoxicity in airway cells 20 , but we excluded cytotoxicity as a mechanism for increased adhesion. In contrast, CSE-exposed cells released moderate levels of LDH, indicating a degree of cellular stress -a finding compatible with a previous studies showing that CS stimulates both oxidative stress and DNA synthesis in A549 cells 21 .
The increased PAFR mRNA transcript level and attenuation of adhesion by the specific PAFR antagonist CV3988 strongly suggests a major role for PAFR in modulating CSE-stimulated pneumococcal adhesion. We did not determine which component (s) of CSE is responsible for increased adhesion-since cigarette smoke is a mixture of thousands of potentially bioactive chemical compounds -including carbonaceous particulate matter, nicotine, alkaloids, metals, nitrosamines, polyaromatic hydrocarbons, aromatic amines, volatile organic compounds 22 , and endotoxin 23 . All combustion sources release inhalable aggregates of carbonaceous nanoparticles (black carbon), and there is strong evidence that black carbon is associated with adverse health effects 24 .
Indeed, we previously found that carbonaceous particles from urban areas in both the UK and Ghana stimulate pneumococcal adhesion to A549 cells 8 .
Undiluted CSE (100%) extract was a black tarry liquid, but when diluted to 1% it did not increase the optical density of the medium. Furthermore, in contrast with our previous study 8 There are limitations to the present study. First, airway epithelial cells in the lung are covered by an anti-oxidant and surfactant-rich layer of epithelial lining fluid 26 . Second, there are other factors that may contribute to cigarette smokeinduced vulnerability to bacterial infection. For example, cigarette smoke attenuates human defensin-2 production 27 , and CSE reduces complement-mediated phagocytosis of S. pneumoniae by murine airway macrophages 4 . Third, cigarette smoke in aqueous solution does not fully reflect the complex behavior and dose of chemicals depositing on cells in vivo -where initial deposition is followed by evaporation then diffusion back to the cell surface 28 . Finally, although we have shown that PAFR has a major role in CSE-stimulated adhesion -we did not measure PAFR expression directly. We uses flow cytometry in an attempt to assess PAFR in A549 cells, but found that CSE increased cellular autofluorescence in a dose-dependent manner and were therefore unable to detect specific immunostaining (data not shown).
In conclusion, we have found evidence of increased expression of PAFR in the bronchial epithelium of active smokers, and have shown that CSE upregulates of pneumococcal adhesion to a lower airway cell line in vitro via PAFR. Since we previously found that PM10 also upregulates pneumococcal adhesion via PAFR 8 , there may be common mechanisms underlying increased risk of bacterial pneumonia resulting from exposure to emissions from a range of combustion fuels/products. 
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